Direct-to-consumer DNA testing firm 23andMe Holding Co said today it would buy privately held company Lemonaid Health for $400 million in a cash-and-stock deal, as it looks to expand into telemedicine, Reuters reports.
Lemonaid Health offers patients direct online access for a number of common conditions, from consultation through treatment. It also offers free and fast delivery of prescription medications. Read more.
